Ginkgo Bioworks Holdings, Inc. vs. Repligen Corp
Repligen Corp (RGEN) comes out ahead, leading on 2 of 2 compared factors.
Size & Scale
| DNA | RGEN | |
|---|---|---|
| Market Cap | $539.34 million | $11.04 billion |
RGEN leads on 1 of 1 size & scale factors.
Risk & Sentiment
| DNA | RGEN | |
|---|---|---|
| Short Interest | 19.24% | 6.30% |
RGEN leads on 1 of 1 risk & sentiment factors.
Dig deeper: DNA overview, DNA financials, RGEN overview, RGEN financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.
